FDA Denies PMRS Petition to Deny Chronic-Use Opioid NDAs

Drug Industry Daily
A A
The FDA denied a petition from Pharmaceutical Manufacturing Research Services (PMRS) asking the agency to set a higher standard for NDAs for abuse-deterrent opioids for treatment of chronic pain.

To View This Article:

Login

Subscribe To Drug Industry Daily